Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
03/14/2013 | WO2012157977A9 Manufacturing method of heterocyclic compound |
03/14/2013 | WO2012148200A9 Composition for aiding surgical procedures for treating ischemic vascular diseases |
03/14/2013 | WO2012101524A3 Radiopaque embolic particles |
03/14/2013 | US20130066069 Processes for preparing substituted pyrimidines |
03/14/2013 | US20130065962 Compounds For Use In The Treatment Of Diseases |
03/14/2013 | US20130065956 Composition and/or method for preventing onset and/or recurrence of cardiovascular events |
03/14/2013 | US20130065954 Ophthalmic uses of s1p receptor modulators |
03/14/2013 | US20130065935 Novel Inhibitors of the Amino Acid Transporters ASCT1 and ASCT2 |
03/14/2013 | US20130065918 Soluble guanylate cyclase activators |
03/14/2013 | US20130065909 Fatty acid fumarate derivatives and their uses |
03/14/2013 | US20130065908 Dihydrofuro pyrimidines as akt protein kinase inhibitors |
03/14/2013 | US20130065903 Method of Improving Diastolic Dysfunction |
03/14/2013 | US20130065899 Heteroaryl compounds and uses thereof |
03/14/2013 | US20130065896 Fused imidazole derivative |
03/14/2013 | US20130065894 6-(4-HYDROXY-PHENYL)-3-STYRYL-1H-PYRAZOLO[3,4-b]PYRIDINE-4-CARBOXYLIC ACID AMIDE DERIVATIVES AS KINASE INHIBITORS |
03/14/2013 | US20130065893 Imidazole derivatives as aldosterone synthase inhibitors |
03/14/2013 | US20130065890 Pyrimidine derivatives |
03/14/2013 | US20130065883 Triazolo [4, 5- B] Pyridin Derivatives |
03/14/2013 | US20130065881 Tricyclic Compounds for Use as Kinase Inhibitors |
03/14/2013 | US20130065880 Compounds as tyrosine kinase modulators |
03/14/2013 | US20130065863 Nitroxyl (hno) releasing compounds and uses thereof in treating diseases |
03/14/2013 | US20130065860 3-(4-(5-phenyl-1 ,2,4-oxadiazol-3-yl)phenoxy)propan-2-ol derivatives as sphingosine-1 phosphate receptors modulators |
03/14/2013 | US20130065859 Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals |
03/14/2013 | US20130065858 Compounds useful as raf kinase inhibitors |
03/14/2013 | US20130065843 Phenolic Compositions Derived From Apple Skin And Uses Thereof |
03/14/2013 | US20130065842 COMPOUNDS AS RORyT MODULATORS AND USES THEREOF |
03/14/2013 | US20130065820 Synthetic myostatin peptide antagonists |
03/14/2013 | US20130065818 Arylamide Compounds And Compositions And Uses Thereof |
03/14/2013 | US20130065817 Polypeptide acting to enhance ischemic diseases |
03/14/2013 | US20130065816 Analogs of pituitary adenylate cyclase-activating polypeptide (pacap) and methods for their use |
03/14/2013 | US20130064904 Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof |
03/14/2013 | US20130064889 Tablet-in-tablet Palperidone Formulations and Methods for Production and Use Thereof |
03/14/2013 | US20130064849 Methods to treat and prevent cardiovascular disease using human papillomavirus vaccines |
03/14/2013 | US20130064832 Notch inhibition in the treatment and prevention of a metabolic disease or disorder and cardiovascular complications thereof |
03/14/2013 | US20130064820 Methods and compositions for treating degos' disease |
03/14/2013 | US20130064806 Novel pharmaceutical salts and polymorphs of a factor xa inhibitor |
03/14/2013 | US20130064804 BIO-REPLENISHMENT (BioRep) FOR IMPROVING SLEEP ARCHITECTURE |
03/14/2013 | US20130064801 Cellular Compositions and Methods of Making and Using Them |
03/14/2013 | US20130064800 Tissue-Engineered Endothelial and Epithelial Implants Differentially and Synergistically Regulate Tissue Repair |
03/14/2013 | US20130064798 Methods and compositions for treating congestive heart failure |
03/14/2013 | US20130064777 Surfactant-free water-free foamable compositions, breakable foams and gels their uses |
03/14/2013 | US20130064766 TRICARBONYL TECHNETIUM-99m OR RHENIUM-188 LABELED CYCLIC RGD DERIVATIVES, A PREPARATION METHOD THEREOF, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVES AS AN ACTIVE INGREDIENT FOR USE IN THE DIAGNOSIS OR TREATMENT OF ANGIOGENESIS-RELATED DISEASES |
03/14/2013 | CA2846667A1 Serpinf2-binding molecules and methods of use |
03/14/2013 | CA2844175A1 Lipophilic dopamine derivatives and their use |
03/13/2013 | EP2567959A1 6-(4-Hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
03/13/2013 | EP2567958A1 Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals |
03/13/2013 | EP2567955A2 Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
03/13/2013 | EP2567701A2 Treatment of heart failure in non-human mammals with an aldosterone antagonist |
03/13/2013 | EP2566880A1 Aromatic-cationic peptides and uses of same |
03/13/2013 | EP2566868A1 Pyrrolo [3, 2 -d]pyrimidin-3 -yl derivatives used as activators of ampk |
03/13/2013 | EP2566861A1 Modulators of fatty acid amide hydrolase |
03/13/2013 | EP2566849A1 8-hydroxy-quinoline derivatives |
03/13/2013 | EP2566502A1 Methods for treating or preventing cardiovascular disorders and providing cardiovascular protection |
03/13/2013 | EP2566478A1 Pharmaceutical composition and method for treating hypertension |
03/13/2013 | EP2407536A9 ADP-ribosyl transferase fusion variant proteins |
03/13/2013 | CN202776947U Scraping plate device with liquid storage bottle |
03/13/2013 | CN202774455U Disease prevention and treatment insole containing traditional Chinese medicine |
03/13/2013 | CN1981776B Composition containing rare ginseng saponin, its production and usage |
03/13/2013 | CN102971324A MTOR selective kinase inhibitors |
03/13/2013 | CN102970994A Compositions and methods related to MIRNA in diabetic conditions |
03/13/2013 | CN102965429A Application of microRNA-320(miR-320A) and its antisense nucleotide in diagnosis, prevention and treatment of cardiovascular diseases |
03/13/2013 | CN102965347A Preparation method of recombinant adeno-associated virus expressing hsa-miR-21<*> and application in treatment of hypertension |
03/13/2013 | CN102965249A Hibiscus sabdariffa nutrition wine and method for preparing same |
03/13/2013 | CN102964453A Osteogenic growth peptide-calcitonin gene related peptide fusion protein and encoding gene thereof |
03/13/2013 | CN102964405A Application of dchydrodiisoeugenol capable of prompting angiogenesis |
03/13/2013 | CN102964403A Gastrodin compound and medicine composition thereof |
03/13/2013 | CN102964354A Thienoimidazole-like derivatives and applications thereof |
03/13/2013 | CN102964302A Morphinan compounds |
03/13/2013 | CN102964238A Bipolar trans-carotenoid salt and application thereof |
03/13/2013 | CN102961729A Externally-used traditional Chinese medicine for treating varicosity, thromboangiitis obliterans and phlebitis |
03/13/2013 | CN102961723A Traditional Chinese medicine composition for treating pediatric viral myocarditis |
03/13/2013 | CN102961703A Traditional Chinese medicine for treating chest discomfort and cardiodynia |
03/13/2013 | CN102961701A Orally administered traditional Chinese medicine composition for treating viral myocarditis |
03/13/2013 | CN102961700A Traditional Chinese medicine preparation for treating chronic pulmonary heart disease |
03/13/2013 | CN102961699A Traditional Chinese medicine for treating chronic pulmonary heart disease |
03/13/2013 | CN102961698A Traditional Chinese medicine preparation for treating chronic rheumatic heart disease |
03/13/2013 | CN102961697A Formula of traditional Chinese medicine for treating chronic rheumatic heart disease |
03/13/2013 | CN102961690A Drug composition used for preventing hypertension complications and application thereof |
03/13/2013 | CN102961684A Medicament for treating arteriosclerosis |
03/13/2013 | CN102961681A Chinese patent medicine for treating viral myocarditis |
03/13/2013 | CN102961672A Medicine for treating cardiovascular disease and painful abdominal mass, and preparation method thereof |
03/13/2013 | CN102961670A Pure traditional Chinese medicine compound preparation for treating hypertension and preparation method thereof |
03/13/2013 | CN102961669A Pure traditional Chinese medicine compound preparation for treating cerebral infarction and preparation method thereof |
03/13/2013 | CN102961645A Heart protecting and meridian dredging granules |
03/13/2013 | CN102961641A Traditional Chinese medicine composition for treating cardiovascular diseases and perspiration syndrome |
03/13/2013 | CN102961625A Traditional Chinese medicine composition for treating chronic pulmonary heart disease |
03/13/2013 | CN102961624A Traditional Chinese medicine for treating viral myocarditis |
03/13/2013 | CN102961623A Chinese patent medicine for treating cardiac neurosis |
03/13/2013 | CN102961622A Traditional Chinese medicine composition for treating chronic rheumatic heart disease |
03/13/2013 | CN102961621A Traditional Chinese medicine preparation for treating viral cardiac neurosis |
03/13/2013 | CN102961620A Formula of traditional Chinese medicine for treating chronic pulmonary heart disease |
03/13/2013 | CN102961614A Traditional Chinese medicine preparation for treating cerebral thrombosis |
03/13/2013 | CN102961609A Dizzy brain smoothing granules |
03/13/2013 | CN102961606A Chinese medicinal composition for treating ischemia apoplexy |
03/13/2013 | CN102961604A Traditional Chinese medicine preparation for treating viral myocarditis |
03/13/2013 | CN102961591A Traditional Chinese medicine composition for tranquilizing mind by nourishing heart |
03/13/2013 | CN102961590A Formula of traditional Chinese medicine for treating viral myocarditis |
03/13/2013 | CN102961575A Formula of traditional Chinese medicine for treating viral cardiac neurosis |
03/13/2013 | CN102961574A Traditional Chinese medicine preparation for treating viral myocarditis |
03/13/2013 | CN102961569A Heart-care medicine composition as well as preparation method and application thereof |